期刊文献+

氨氯地平联合贝那普利治疗老年单纯收缩期高血压疗效观察 被引量:6

Effect of Amlodipine and Benazepril Treating the Isolated Systolic Hypertension in the Elderly(EISH)
下载PDF
导出
摘要 目的:探讨氨氯地平联合贝那普利治疗老年单纯收缩期高血压的疗效。方法:选择86例老年单纯收缩期高血压患者,给予苯磺酸氨氯地平5mg,贝那普利10mg,若血压不达标,氨氯地平加量至10mg,服药时间一般为早晨6~8点,连续服用3个月。结果:经过3个月治疗后,收缩压和舒张压均明显低于治疗前,总有效率93.02%。结论:氨氯地平联合贝那普利治疗老年单纯收缩期高血压疗效显著,值得推广。 Objective:To discuss the effect of Amlodipine and Benazepril treating the isolated systolic hypertension in the elderly.Method:The patients were gave 5mg Amlodipine and 10mg Benazepril for 3 months.If the blood pressure did not reach the standard,the dosage of Amlodipine were up to 10mg.Results:After 3 months after treatment,systolic and diastolic blood pressure were significantly lower than before treatment,the total efficiency of 93.02%.Conclusion:To combine Amlodipine with Benazepri may be an ideal method for the isolated systolic hypertension in the elderly.
出处 《辽宁中医药大学学报》 CAS 2011年第4期212-213,共2页 Journal of Liaoning University of Traditional Chinese Medicine
关键词 氨氯地平 贝那普利 单纯收缩期高血压 amlodipine benazepril isolated systolic hypertension
  • 相关文献

参考文献3

二级参考文献5

  • 1Yusuf S, Diener HC,Sacco RL, et al. Telmisartan to prevent recurrent stroke and cardiovascular events [ J ]. N Engl J Med, 2008, 359:1225 - 1237. 被引量:1
  • 2TRANSCEND Investigators. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in hlgh-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial[ J ]. Lancet,2008,372 (9) : 1174 - 1183. 被引量:1
  • 3Yusuf S ,Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events[J]. N Engl J Med,2008, 358 : 1547 - 1559. 被引量:1
  • 4Kjeldsen SE, Jamerson KA, Bakris GL, et al. Predictors of blood pressure response to intensified and fixed combination treatment of hypertension:the ACCOMPLISH study [ J ]. Blood Press ,2008,17: 7 -17. 被引量:1
  • 5ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outoomes in high-risk hypertensive patients randomized to angiotensin-eonverting enzyme inhibitor or calcium channel blocker vs diuretic : the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [ J]. JAMA ,2002,288:2981 - 2997. 被引量:1

共引文献2801

同被引文献27

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部